SU607534A3 - Способ получени средств, обладающего фунгистатическим и фунгицидным дествием - Google Patents

Способ получени средств, обладающего фунгистатическим и фунгицидным дествием

Info

Publication number
SU607534A3
SU607534A3 SU752172908A SU2172908A SU607534A3 SU 607534 A3 SU607534 A3 SU 607534A3 SU 752172908 A SU752172908 A SU 752172908A SU 2172908 A SU2172908 A SU 2172908A SU 607534 A3 SU607534 A3 SU 607534A3
Authority
SU
USSR - Soviet Union
Prior art keywords
fungicidic
fungistasis
effect
substance possessing
compositions
Prior art date
Application number
SU752172908A
Other languages
English (en)
Inventor
Полак-Висс Аннемари
Шолер Ханс
Original Assignee
Ф.Гоффманн-Ля Рош И Ко, Аг (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.Гоффманн-Ля Рош И Ко, Аг (Фирма) filed Critical Ф.Гоффманн-Ля Рош И Ко, Аг (Фирма)
Application granted granted Critical
Publication of SU607534A3 publication Critical patent/SU607534A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Description

борьбы с заражени ми,вызванными гри0ами и дрожжами, рода iCawdida,CryT3t Qccus ,3pofolricV uttt, A&73et giEBus или Saejtafoitiauee .: и примен етс  дл  лечени  повёрхностньк заражени1й кржи и слизистых Оболочек, желудочно-кишечного тракта, вагинита. Примен ют это средстэо в виде мазей, суппозиторий , свечей, овул торных средств Пример 1. Влагалищна  таблетка содержаща , мг: . Кандицидинт5
5-Фторцито3ИИ1000
.Вторичный фосфат кальци 2Hibзао ,о
Прессуемый крахмал 203 Молочный сахар (высушенный распылением)100
Поливинилпирролидон 30 Лимонна  кислота
(безводна ),5,0
Стеарат магни 7,0
П р и м е р 2 . Влагалищна  таблетка , содержаща , мг: Нистанин 25
5-ФторцитозинЮОО
Вторичный фосфат
кальци ЯН О 280
Прессуемый крахмал203
Молочный сахар
(высушенный, распылением) ЮО Поливинилпирролидон30
Лимонна  кислота
{безводна )5,0
Стеарат магни 7,0
П р и м е р 3. Влагалищна  таблетка , содержаща , мг: -Трихомицин5,0
5-Фторцитозин500
Вторичный фосфат
2Я20 кали 
300
Прессуемый крахмал
208 Молочный сахар
550 . Поливинилпирролидон
25 Лимонна  кислота
5,0 Стеарат магни 
7,0
П р и м е р 4. Мазь дл  введени  во влагалище, содержаща , мг: Гидрохл9Рид сложного кандицидинметилового эфира 0,5 5-фторцитозин 10,00 Кетиловый спирт3,60
Ланолин9,0
Вазелин белый70,00
Парафиновое масло7,35
15
Предлагаемый способ обеспечивает получение средства, обладающего высокой фунгистатической и фунгицидной
активностью.

Claims (2)

1.Томилина Т. Н. , Рецептурный справочник дл  врачей, М,, 1973,
стр. 255.
2. JoufHQE of AHiibiotice. 28, 1975, P. 244-245.
SU752172908A 1974-09-20 1975-09-19 Способ получени средств, обладающего фунгистатическим и фунгицидным дествием SU607534A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1279774 1974-09-20

Publications (1)

Publication Number Publication Date
SU607534A3 true SU607534A3 (ru) 1978-05-15

Family

ID=4386491

Family Applications (1)

Application Number Title Priority Date Filing Date
SU752172908A SU607534A3 (ru) 1974-09-20 1975-09-19 Способ получени средств, обладающего фунгистатическим и фунгицидным дествием

Country Status (16)

Country Link
AT (1) AT339471B (ru)
AU (1) AU476206B2 (ru)
BE (1) BE833589A (ru)
CU (1) CU34348A (ru)
DD (1) DD122023A5 (ru)
DE (1) DE2540799A1 (ru)
FR (1) FR2285133A1 (ru)
GB (1) GB1472046A (ru)
HU (1) HU172247B (ru)
IE (1) IE41720B1 (ru)
IL (1) IL48039A0 (ru)
LU (1) LU73422A1 (ru)
NL (1) NL7511001A (ru)
SE (1) SE7510429L (ru)
SU (1) SU607534A3 (ru)
ZA (1) ZA755632B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2536492C2 (ru) * 2008-08-01 2014-12-27 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Применение 5-фторцитозина в качестве фунгицида

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2012118395A (ru) * 2009-10-07 2013-11-20 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Синергическая фунгицидная композиция, содержащая 5-фторцитозин, для борьбы с грибковыми болезнями зерновых культур

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2536492C2 (ru) * 2008-08-01 2014-12-27 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Применение 5-фторцитозина в качестве фунгицида

Also Published As

Publication number Publication date
ZA755632B (en) 1976-08-25
DE2540799A1 (de) 1976-04-01
ATA719775A (de) 1977-02-15
IL48039A0 (en) 1975-11-25
BE833589A (fr) 1976-03-19
LU73422A1 (ru) 1977-05-16
NL7511001A (nl) 1976-03-23
AU476206B2 (en) 1976-09-16
FR2285133A1 (fr) 1976-04-16
IE41720B1 (en) 1980-03-12
SE7510429L (sv) 1976-03-22
AT339471B (de) 1977-10-25
AU8456875A (en) 1976-09-16
GB1472046A (en) 1977-04-27
IE41720L (en) 1976-03-20
DD122023A5 (ru) 1976-09-12
HU172247B (hu) 1978-07-28
CU34348A (es) 1979-09-08

Similar Documents

Publication Publication Date Title
US3091569A (en) Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
DK0501985T3 (da) Uovertrukket farmaceutisk reaktionstablet
CA2248179A1 (en) .beta.-lactam antibiotic-containing tablet and production thereof
ATE180668T1 (de) S(+)-ibuprofen enthaltende arzneimittel
US5573765A (en) Composition and method for treatment of vaginal yeast infections
DE58902457D1 (de) Retardierte arzneiform und verfahren zu ihrer herstellung.
AU732792B2 (en) Composition and method for the treatment of vaginal yeast infections
ES546799A0 (es) Procedimiento para la obtencion de formulaciones medicionales solidas de nitrendipina cristalina.
AU2142988A (en) Antiviral compounds
SU607534A3 (ru) Способ получени средств, обладающего фунгистатическим и фунгицидным дествием
IE43693L (en) Androstane derivatives
GR3032800T3 (en) Active substance complex for the production of biological parts, especially organs for living organisms; process for its production and its use.
ES2145360T3 (es) Sales cristalinas y estables de acido tetrahidrofolico.
IE791995L (en) Formulation
JPS57146722A (en) Pharmaceutical preparation having improved absorption
US5118799A (en) Process for converting crystalline erythromycin ethylsuccinate into stable amorphous erythromycin ethylsuccinate
ES475660A1 (es) Un procedimiento para la preparacion de un tiol acido y sus sales y esteres
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
McKinnon et al. A new treatment for yeast vaginitis
GB1292496A (en) Dosage units of contraceptive preparations for human use
GB1360032A (en) 2-thio-5-azocytosine and its nucleosides
NL7810163A (nl) Arylalkylalkaancarbonzuren, geneesmiddel met als werk- zaam bestanddeel alkaancarbonzuur en werkwijze voor de bereiding van de arylalkylalkaancarbonzuren.
EP0291488A2 (en) Erythromycin derivative and the preparation and use thereof
JPS5436291A (en) Preparation of theobromine derivative
CA2022323A1 (en) Excretion of potassium ion by prostanoic acid derivatives